Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2026-03-12 @ 5:30 AM
Study NCT ID:
NCT00750633
Status:
COMPLETED
Last Update Posted:
2012-12-03
First Post:
2008-09-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Study of an Otic Formulation in Acute Otitis Externa
Sponsor:
Alcon Research
Organization:
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if an otic formulation is safe and effective for the treatment of acute otitis externa (AOE).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: